Adage Capital Partners Gp, L.L.C. Biomea Fusion, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 900,000 shares of BMEA stock, worth $3.81 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
900,000
Previous 1,100,000
18.18%
Holding current value
$3.81 Million
Previous $4.95 Million
83.64%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BMEA
# of Institutions
104Shares Held
17.8MCall Options Held
1.68MPut Options Held
410K-
Cormorant Asset Management, LP Boston, MA3.57MShares$15.1 Million2.53% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$9.92 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$8.92 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$5.91 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.38MShares$5.83 Million0.01% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $124M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...